Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 5, 2009, Pages 1115-1122

  Alserius, Thomas ^a,b   Hammar, Niklas ^b   Nordqvist, Tobias ^b   Ivert, Torbjörn ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; GENDER; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL; VASCULAR DISEASE;

AGED; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE;

EID: 72049093759     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.03.013     Document Type: Article

References (37)

1. Carson J.L., Scholz P.M., Chen A.Y., Peterson E.D., Gold J., and Schneider S.H. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40 (2002) 418-423
2. Schwartz L., Kip K.E., Frye R.L., Alderman E.L., Schaff H.V., and Detre K.M. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106 (2002) 2652-2658
3. Dortimer A.C., Shenoy P.N., Shiroff R.A., Leaman D.M., Babb J.D., Liedtke A.J., et al. Diffuse coronary artery disease in diabetic patients: fact or fiction?. Circulation 57 (1978) 133-136
4. Ledru F., Ducimetiere P., Battaglia S., Courbon D., Beverelli F., Guize L., et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 37 (2001) 1543-1550
5. Thourani V.H., Weintraub W.S., Stein B., Gebhart S.S., Craver J.M., Jones E.L., et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 67 (1999) 1045-1052
6. Calafiore A.M., Di Mauro M., Di Giammarco G., Contini M., Vitolla G., Iaco A.L., et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 125 (2003) 144-154
7. Woods S.E., Smith J.M., Sohail S., Sarah A., and Engle A. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: an 8-year prospective cohort study. Chest 126 (2004) 1789-1795
8. Alserius T., Hammar N., Nordqvist T., and Ivert T. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J 152 (2006) 599-605
9. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
10. Rajakaruna C., Rogers C.A., Suranimala C., Angelini G.D., and Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg 132 (2006) 802-810
11. Hakala T., Pitkanen O., Halonen P., Mustonen J., Turpeinen A., and Hippelainen M. Early and late outcome after coronary artery bypass surgery in diabetic patients. Scand Cardiovasc J 39 (2005) 177-181
12. Hueb W., Gersh B.J., Costa F., Lopes N., Soares P.R., Dutra P., et al. Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease. Ann Thorac Surg 83 (2007) 93-99
13. Kubal C., Srinivasan A.K., Grayson A.D., Fabri B.M., and Chalmers J.A. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 79 (2005) 1570-1576
14. Szabo Z., Hakanson E., and Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 74 (2002) 712-719
15. Toumpoulis I.K., Anagnostopoulos C.E., Balaram S.K., Rokkas C.K., Swistel D.G., Ashton Jr. R.C., et al. Assessment of independent predictors for long-term mortality between women and men after coronary artery bypass grafting: are women different from men?. J Thorac Cardiovasc Surg 131 (2006) 343-351
16. Mohammadi S., Dagenais F., Mathieu P., Kingma J.G., Doyle D., Lopez S., et al. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 116 (2007) I220-I225
17. Luciani N., Nasso G., Gaudino M., Abbate A., Glieca F., Alessandrini F., et al. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up. Ann Thorac Surg 76 (2003) 1149-1154
18. Daemen J., and Serruys P.W. Optimal revascularization strategies for multivessel coronary artery disease. Curr Opin Cardiol 21 (2006) 595-601
19. Cockroft W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
20. Muller C., Neumann F.J., Ferenc M., Perruchoud A.P., and Buttner H.J. Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy. Diabetologia 47 (2004) 1188-1195
21. Echahidi N., Pibarot P., Despres J.P., Daigle J.M., Mohty D., Voisine P., et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 50 (2007) 843-851
22. Smith Jr. S.C., Dove J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 103 (2001) 3019-3041
23. Pell J.P., Pell A.C., Jeffrey R.R., Jennings K., Oldroyd K., Eteiba H., et al. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures. Diabet Med 21 (2004) 790-792
24. Abizaid A., Costa M.A., Centemero M., Abizaid A.S., Legrand V.M., Limet R.V., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104 (2001) 533-538
25. Niles N.W., McGrath P.D., Malenka D., Quinton H., Wennberg D., Shubrooks S.J., et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 37 (2001) 1008-1015
26. Gandjbakhch I., Leprince P., D'Alessandro C., Ouattara A., Bonnet N., Varvous S., et al. [Coronary artery bypass graft surgery in patients with diabetes]. Bull Acad Natl Med 189 (2005) 257-267
27. Flaherty J.D., and Davidson C.J. Diabetes and coronary revascularization. JAMA 293 (2005) 1501-1508
28. Amos A.F., McCarty D.J., and Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14 suppl 5 (1997) S1-S85
29. Leavitt B.J., Sheppard L., Maloney C., Clough R.A., Braxton J.H., Charlesworth D.C., et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110 (2004) II41-II44
30. Anderson R.E., Brismar K., and Ivert T. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines. Diab Vasc Dis Res 4 (2007) 112-116
31. Anderson R.E., Klerdal K., Ivert T., Hammar N., Barr G., and Owall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?. Eur Heart J 26 (2005) 1513-1518
32. Estrada C.A., Young J.A., Nifong L.W., and Chitwood Jr. W.R. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75 (2003) 1392-1399
33. Stratton I.M., Cull C.A., Adler A.I., Matthews D.R., Neil H.A., and Holman R.R. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49 (2006) 1761-1769
34. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355 (2000) 253-259
35. Collins R., Armitage J., Parish S., Sleigh P., and Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
36. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 854-865
37. Belcher P.R., Gaw A., Cooper M., Brown M., Wheatley D.J., and Lindsay G.M. Are we negating the benefits of CABG by forgetting secondary prevention?. J Hum Hypertens 16 (2002) 691-697